Risk assessment model for first-cycle chemotherapy-induced neutropenia in patients with solid tumours
about
A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma.Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factorsFebrile neutropenia in chemotherapy treated small-cell lung cancer patientsChemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy.Prognostic Value of Chemotherapy-Induced Neutropenia at the First Cycle in Invasive Breast Cancer.External validation of a risk model of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma.Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial.History of chronic comorbidity and risk of chemotherapy-induced febrile neutropenia in patients with non-Hodgkin lymphoma not receiving granulocyte colony-stimulating factor prophylaxis.
P2860
Q33407574-21F3AB27-1677-41EA-9DBC-B488FA35DE7AQ35123683-5CE8711E-684A-42E7-972D-BCE9BB9D09A3Q35297079-23ED62A6-EE4B-4C7A-9BEE-319366F50C83Q36106810-45B2C7E7-43DF-4995-BB7D-65C95E52B322Q37205943-404FC4E8-2C25-40B0-9094-AB76373E326FQ44569718-68ABA0FC-DB28-4610-A9CD-49EC4932220AQ45070735-4357C0DC-A670-490C-B2B0-B3B0CF087501Q46826040-FF585D1A-0AE8-46ED-930F-4FB54845133C
P2860
Risk assessment model for first-cycle chemotherapy-induced neutropenia in patients with solid tumours
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Risk assessment model for firs ...... in patients with solid tumours
@ast
Risk assessment model for firs ...... in patients with solid tumours
@en
Risk assessment model for firs ...... in patients with solid tumours
@nl
type
label
Risk assessment model for firs ...... in patients with solid tumours
@ast
Risk assessment model for firs ...... in patients with solid tumours
@en
Risk assessment model for firs ...... in patients with solid tumours
@nl
prefLabel
Risk assessment model for firs ...... in patients with solid tumours
@ast
Risk assessment model for firs ...... in patients with solid tumours
@en
Risk assessment model for firs ...... in patients with solid tumours
@nl
P2093
P2860
P1476
Risk assessment model for firs ...... in patients with solid tumours
@en
P2093
A Casas de Tejerina
A López-Pousa
C Iglesias
DELFOS Study Group
J A Gasquet
J L González-Larriba
P2860
P304
P356
10.1111/J.1365-2354.2009.01121.X
P407
P577
2010-01-19T00:00:00Z